Stocky turns companies like DR MARTENS PLC into a fun, safe way to learn investing — a virtual portfolio, live scores & charts, and real analyst data, with no real money.
Try Stocky free →Cautious. DOCMF's moderate valuation (15.5x forward P/E) and balanced Value Compounder profile (56/100) offer modest downside protection, but weak growth momentum (48/100 Growth Compounder Score) and leadership alignment concerns (59/100) limit upside. The company relies primarily on financial reserves to weather headwinds rather than competitive strength, signaling structural fragility.
Every stock is scored across six proprietary dimensions built for retail investors who want Buffett-quality analysis without a Bloomberg subscription. Here's the actual snapshot for DR MARTENS PLC:
Quality + moat + leadership + valuation + sentiment fused into a single 0–100 number. When you see 59/100, you know instantly whether to dig deeper or skip.
Pricing power, switching costs, network effects, and 10-year ROIC data. Same framework Morningstar charges for — free inside Stocky.
Founder tenure, insider ownership, CEO pay reasonableness, long-term value creation. Six factors, one score — turns "trust the CEO" into evidence.
Customer concentration, supply chain, refinancing walls, regulatory exposure. Stocky maps knowable fragilities so you're never blindsided.
Every score backtested against real S&P 500 returns. See how "Elite" (90+ Verdict) picks have performed vs the index — no black boxes.
Analyst target shifts, insider buys, big moves — plus a monthly Portfolio Health Report telling you what's actually driving your returns.
Stocky rates DR MARTENS PLC (DOCMF) at 59/100 — below the bar Stocky looks for. The score fuses business quality, moat width, leadership alignment, valuation and analyst signal into a single number. Cautious. DOCMF's moderate valuation (15.5x forward P/E) and balanced Value Compounder profile (56/100) offer modest downside protection, but weak growth momentum (48/100 Growth Compounder Score) and leadership alignment concerns (59/10
DOCMF's current Stocky Verdict is 59/100, placing it in the "Cautious" band. This composite combines a 56/100 Compounder score, 59/100 Leadership, Moat rating, and analyst signal.
Stocky hasn't finalised a Moat Score for DR MARTENS PLC yet — the analysis draws from ROIC trends, pricing power evidence, and competitive-position filings.
DR MARTENS PLC scores 59/100 on Leadership Alignment. Higher = more founder involvement, higher insider ownership, sensible pay, and evidence of long-term capital allocation discipline.
DR MARTENS PLC's Vulnerability Profile scores 100/100 (higher = more resilient). The profile flags customer concentration, supply chain, refinancing walls and regulatory risks specific to DR MARTENS PLC.
Sign up free and unlock the full analysis on DOCMF — the same tools professional analysts use, personalised to your portfolio:
Free forever tier includes 5 Verdict lookups a day. Plus €19/mo unlocks everything above. Cancel any time.
This page is just a preview. Open the live, interactive version for the full picture:
Or jump straight to the interactive dashboard for DOCMF in the app.
